FindTrial
Sign In

supportive

OTHER2 trials

Sponsors

All India Institute of Medical Sciences, Beijing Biotech

Conditions

Epithelial Ovarian CancerFallopian Tube CarcinomaHepatocellular CarcinomaPrimary Peritoneal CarcinomaRecurrent or Refractory Disease After Standard Therapies

Phase 1

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2
RecruitingNCT07617753
Beijing BiotechEpithelial Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma +1
Start: 2026-03-02End: 2028-03-17Target: 36Updated: 2026-06-01

Phase 2

Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma
NCT01438450
All India Institute of Medical SciencesHepatocellular Carcinoma
Start: 2007-10-31End: 2014-09-30Target: 74Updated: 2012-07-13